[The elderly patient in cardiology]

Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|September 22, 1992
PubMed

Insights

Cardiovascular disease in the elderly requires tailored treatments for conditions like hypertension and heart failure. Early intervention with thrombolytic therapy and consideration of procedures like angioplasty are vital for better outcomes in older patients.

Area of Science:

  • Geriatric Cardiology
  • Internal Medicine
  • Clinical Therapeutics

Context:

  • Cardiovascular diseases (CVD) present unique challenges in the elderly population.
  • Age-related physiological changes impact disease presentation and treatment response.
  • Comorbidities are highly prevalent in older adults with CVD.

Purpose:

  • To outline the specific considerations for managing cardiovascular disease in elderly patients.
  • To discuss therapeutic strategies for common CVDs in geriatrics.
  • To highlight the applicability and special considerations for interventions in octogenarians.

Summary:

  • Elderly patients with arterial hypertension, heart failure, and electrical disturbances often necessitate distinct therapeutic approaches.
  • Myocardial infarction in the elderly can be severe, underscoring the importance of considering thrombolytic therapy.
  • Coronary angioplasty and cardiac surgery are viable options for patients over 80, provided their functional status and comorbidities are carefully assessed.

Impact:

  • Informs clinical decision-making for geriatric cardiovascular care.
  • Promotes optimized treatment strategies for cardiovascular conditions in older adults.
  • Encourages the consideration of advanced cardiac interventions in the elderly based on individual patient profiles.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...